| Health / Medical Topics |
PR7V10 (ras-12 Ala) Peptide
A natural or synthetic peptide derived from the Ras protein with potential use in cancer immunotherapy. Ras protein regulates a number of signalling molecules by translocating them to the plasma membrane for activation and may serve as a branchpoint in signal transduction because it orchestrates the activity of multiple signalling pathways to regulate diverse cellular functions. Ras-12 Ala is a mutated form of the wild-type Ras protein in which the amino acid glycine at codon 12 is replaced with alanine. Vaccination with mutated Ras proteins or peptides may stimulate cytotoxic host immune responses to tumor cells that express similarly mutated Ras proteins. (NCI Thesaurus)
YOU MAY ALSO LIKE
A truncated synthetic form of the oncogene Ras, whose protein product p21 is located in the plasma membrane and transduces growth and…
A truncated synthetic form of the oncogene Ras, whose protein product p21 is located in the plasma membrane and transduces growth and…
A synthetic form of the ras peptide containing a point mutation at position 12 (glycine to cysteine). Vaccines using mutant ras peptides…
A cancer vaccine containing PR1, a 9 amino-acid human leukocyte antigen (HLA)-A2 restricted peptide derived from proteinase 3, with potential immunotherapeutic…
Describes cells that have a protein to which the hormone progesterone will bind. Cancer cells that are PR+ need progesterone to grow…
A synthetic form of the ras peptide containing a point mutation at position 12 (glycine to valine). Vaccines using mutant ras peptides…
